SARS-CoV-2-IN-31

Modify Date: 2025-08-23 09:07:15

SARS-CoV-2-IN-31 Structure
SARS-CoV-2-IN-31 structure
Common Name SARS-CoV-2-IN-31
CAS Number 1017691-52-9 Molecular Weight 464.56
Density N/A Boiling Point N/A
Molecular Formula C29H28N4O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SARS-CoV-2-IN-31


SARS-CoV-2-IN-31 is an effective COVID-19 inhibitor. SARS-CoV-2-IN-31 exhibits excellent to mild activity against various cancer cell lines with IC50 values range from 28.84 to 38.36 μM. SARS-CoV-2-IN-31 can be used for the research of cancer[1].

 Names

Name SARS-CoV-2-IN-31

 SARS-CoV-2-IN-31 Biological Activity

Description SARS-CoV-2-IN-31 is an effective COVID-19 inhibitor. SARS-CoV-2-IN-31 exhibits excellent to mild activity against various cancer cell lines with IC50 values range from 28.84 to 38.36 μM. SARS-CoV-2-IN-31 can be used for the research of cancer[1].
Related Catalog
Target

IC50: 38.36 μM (MCF-7); 38.46 μM (MDA-MB-231); 28.84 μM (HeLa); 30.62 μM (PC-3); >40 μM (Ishikawa)[1]

In Vitro SARS-CoV-2-IN-31 exhibits antiproliferative activity in five different human cancer cell lines with IC50 values of 38.36 μM (MCF-7), 38.46 μM (MDA-MB-231), 28.84 μM (HeLa), 30.62 μM (PC-3) and >40 μM (Ishikawa), respectively[1]. SARS-CoV-2-IN-31 shows comparatively high binding affinity with value of -8.3 Kcal/mole[1]
References

[1]. Anamika Gupta, et al. Visible Light-Promoted Green and Sustainable Approach for One-Pot Synthesis of 4,4’-(Arylmethylene)bis(1H-pyrazol-5-ols), In Vitro Anticancer Activity, and Molecular Docking with Covid-19 Mpro. ACS Omega 2022.

 Chemical & Physical Properties

Molecular Formula C29H28N4O2
Molecular Weight 464.56
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.